Scientific publications

A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies

Julien Valton, Valerie Guyot, Bijan Boldajipour, Cesar Sommer, Thomas Pertel, Alexandre Juillerat, Aymeric Duclert, Barbra Johnson Sasu, Philippe Duchateau & Laurent Poirot
Scientific Reportsvolume 8, Article number: 8972 (2018) June 12, 2018
Read now

Fine and predictable tuning of TALEN gene editing targeting for improved T-cell adoptive immunotherapy

Anne-Sophie Gautron, Alexandre Juillerat, Valérie Guyot, Jean-Marie Filhol, Emilie Dessez, Aymeric Duclert, Philippe Duchateau and Laurent Poirot
Molecular Therapy - Nucleic Acids Volume 9, December 15, 2017
Read now

Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells

Francesca Stillitano, Jens Hansen, Chi-Wing Kong, Ioannis Karakikes, Christian Funck-Brentano, Lin Geng, Stuart Scott, Stephan Reynier, Ma Wu, Yannick Valogne, Carole Desseaux, Joe-Elie Salem, Dorota Jeziorowska, Noël Zahr, Ronald Li, Ravi Iyengar, Roger J Hajjar, Jean-Sébastien Hulot
Elife. 2017 Jan 30
Read now

An oxygen sensitive self-decision making engineered CAR T-cell

Alexandre Juillerat, Alan Marechal, Jean Marie Filhol, Yannick Valogne, Julien Valton, Aymeric Duclert, Philippe Duchateau and Laurent Poirot
Scientific Reports 7, Article number: 39833 (2017) doi:10.1038/srep39833
Read now

TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors

Laurie Menger, Anna Sledzinska, Katharina Bergerhoff, Frederick Arce Vargas, Julianne Smith, Laurent Poirot, Martin Pule, Javier Hererro, Karl S. Peggs, and Sergio A. Quezada
Cancer Research April 15, 2016
Read now